BioCentury
ARTICLE | Financial News

ImmunoCellular amends follow-on

August 8, 2016 7:00 AM UTC

ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC), Calabasas, Calif. Business: Cancer Date announced: 2016-08-02 Type: Follow-on To be raised: Up to $20.1 million Shares: 51.5 million Price prior: $0.27 ...